Transgenic mice overexpressing aldose reductase in Schwann cells show more severe nerve conduction velocity deficit and oxidative stress under hyperglycemic stress

Molecular and Cellular Neuroscience

Volumn 23, Issue 4, 2003, Pages 638-647

  Song, Zhentao ^a   Fu, Douglas T W ^a   Chan, Ying Shing ^b   Leung, Suetyi ^b   Chung, Stephen S M ^a   Chung, Sookja K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; BIOLOGICAL MARKER; GALACTITOL; GLUTATHIONE; MESSENGER RNA; MYELIN PROTEIN; SORBITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GALACTOSEMIA; GENE CONTROL; GENE OVEREXPRESSION; HYPERGLYCEMIA; MALE; MOTOR NERVE CONDUCTION; MOUSE; NERVE CONDUCTION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; SCHWANN CELL; SCIATIC NERVE; STRESS; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0042160232     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-7431(03)00096-4     Document Type: Article

References (32)

1. Calcutt N.A., Tomlinson D.R., Biswas S. Coexistence of nerve conduction deficit with increased Na(+)-K(+)-ATPase activity in galactose-fed mice implications for polyol pathway and diabetic neuropathy . Diabetes. 39:1990;663-666.
2. Calcutt N.A., Willars G.B., Tomlinson D.R. Statil-sensitive polyol formation in nerve of galactose-fed mice. Metabolism. 37:1988;450-453.
3. Cameron N.E., Cotter M.A., Basso M., Hohman T.C. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia. 40:1997;271-281.
4. Cameron N.E., Cotter M.A., Dines K., Love A. Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia. 35:1992;946-950.
5. Chung S., LaMendola J. Cloning and sequence determination of human placental aldose reductase gene. J. Biol. Chem. 264:1989;14775-14777.
6. Conti A.M., Scarpini E., Malosio M.L., Di Giulio A.M., Baron P., Scarlato G., Mantegazza P., Gorio A. In situ hybridization study of myelin protein mRNA in rats with an experimental diabetic neuropathy. Neurosci. Lett. 22:1996;65-69.
7. Finegold D., Lattimer S.A., Nolle S., Bernstein M., Greene D.A. Polyol pathway activity and myo-inositol metabolism a suggested relationship in the pathogenesis of diabetic neuropathy . Diabetes. 32:1983;988-992.
8. Gabbay K.H. The sorbitol pathway and the complications of diabetes. N. Engl. J. Med. 288:1973;831-836.
9. Greene D.A., Stevens M.J., Obrosova I., Feldman E.L. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. Eur.J. Pharmacol. 375:1999;217-223.
10. Hohman T.C., Banas D., Basso M., Cotter M.A., Cameron N.E. Cyclooxygenase-dependent effect of pentoxifylline on neurovascular function in diabetic rats. Diabetologia. 40:(Suppl.):1997;A549. [Abstract].
11. Hounsom L., Tomlinson D.R. Does neuropathy develop in animal models? Clin. Neurosci. 4:1997;380-389.
12. Jiang Z.Y., Zhou Q.L., Eaton J.W., Koppenol W.H., Hunt J.V., Wolff S.P. Spirohydantoin inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro. Biochem. Pharmacol. 42:1991;1273-1278.
13. Kador P.F., Kinoshita J.H. The identification of aldose reductase in the pathogenesis of diabetic complications the background . Diabet. Med. 2:1985;187-189.
14. Lal S., Szwergold B.S., Taylor A.H., Randall W.C., Kappler F., Brown T.R. Production of fructose and fructose-3-phosphate in maturing rat lenses. Invest. Ophthalmol. Vis. Sci. 36:1995;969-973.
15. Lee A.Y., Chung S.K., Chung S.S. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc. Natl. Acad. Sci. USA. 92:1995;2780-2784.
16. Lee A.Y., Chung S.S. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J. 13:(1):1999;23-30.
17. Lee F.K., Lee A.Y., Lin C.X., Chung S.S., Chung S.K. Cloning, sequencing, and determination of the sites of expression of mouse sorbitol dehydrogenase cDNA. Eur. J. Biochem. 230:1995;1059-1065.
18. Malik S., Sami M., Watts A. A role for band 4.2 in human erythrocyte band 3 mediated anion transport. Biochemistry. 32:1993;10078-10084.
19. Messing A., Behringer R.R., Hammang J.P., Palmiter R.D., Brinster R.L., Lemke G. P0 promoter directs expression of reporter and toxin genes to Schwannn cells of transgenic mice. Neuron. 8:1992;507-520.
20. Mizisin A.P., Li L., Calcutt N.A. Sorbitol accumulation and transmembrane efflux in osmotically stressed JSI schwannoma cells. Neurosci. Lett. 229:1997;53-56.
21. Ng T.F., Lee F.K., Song Z.T., Calcutt N.A., Lee A.Y., Chung S.S., Chung S.K. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice. Diabetes. 47:1998;961-966.
22. Nishimura C., Graham C., Hohman T.C., Nagata M., Robison W.G. Jr., Carper D. Characterization of mRNA and genes for aldose reductase in rat. Biochem. Biophys. Res. Commun. 153:1988;1051-1059.
23. Obrosova I.G., Lang H.J., Greene D.A. Antioxidative defense in diabetic peripheral nerve role for aldose reductase and sorbitol dehydrogenase . Diabetologia. 41:(Suppl.):1998;A270. [Abstract].
24. Reeves R.E., Cammarata P.R. Osmoregulatory alterations in myo-inositol uptake by bovine lens epithelial cells. Part 5. Mechanism of the myo-inositol efflux pathway. Invest. Ophthalmol. Vis. Sci. 37:1996;619-629.
25. Tesfaye S., Malik R., Ward J.D. Vascular factors in diabetic neuropathy. Diabetologia. 37:1994;847-854.
26. Van Heyningen R. Formation of polyols by the lens of the rat with 'sugar' cataract. Nature. 184:1959;194-195.
27. Wolff S.P., Dean R.T. Glucose autoxidation and protein modification the potential role of 'autoxidative glycosylation' in diabetes . Biochem. J. 245:1987;243-250.
28. Wong E., Mizisin A.P., Garrett R.S., Miller A.L., Powell H.C. Changes in aldose reductase after crush injury of normal rat sciatic nerve. J. Neurochem. 58:1992;2212-2220.
29. Yagihashi S., Yamagishi S.I., Wada R., Sugimoto K., Baba M., Wong H.G., Fujimoto J., Nishimura C., Kokai Y. Galactosemic neuropathy in transgenic mice for human aldose reductase. Diabetes. 45:1996;56-59.
30. Yagihashi S., Yamagishi S.I., Wada R., Baba M., Hohman T.C., Yabe-Nishimura C., Kokai Y. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Brain. 124:2001;2448-2458.
31. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269:1994;9889-9897.
32. Yue D.K., Hanwell M.A., Satchell P.M., Turtle J.R. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats. Diabetes. 31:1982;789-794.